Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03649555 · ClinicalTrials.gov registry record · Phase 1
Reliability of [18F]-FTC-146 Brain Uptake in Healthy Controls
A Phase 1 study, sponsored by Stanford University.
- Completed
- Registry status
- Phase 1
- Development phase
- 5
- Enrollment target
NCT03649555: Completed Phase 1 study, sponsored by Stanford University.
NCT03649555 is a Phase 1 study that has completed, run by Stanford University. The registered enrollment target is 5 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03649555, a Phase 1 study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 5 participants
- Enrollment target
Study Summary
The purpose of this study is to understand the reliability of \[18F\]-FTC-146 brain uptake in healthy controls.
Interventions
- DRUG [18F]-FTC-146
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2019-02-01 |
| Est. Completion | 2021-03-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03649555
The ClinicalTrials.gov registry entry for NCT03649555 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which [18F]-FTC-146 is the first listed.
NCT03649555 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03649555 about?
NCT03649555 is a clinical study titled "Reliability of [18F]-FTC-146 Brain Uptake in Healthy Controls". The purpose of this study is to understand the reliability of \[18F\]-FTC-146 brain uptake in healthy controls.
What is the current status of trial NCT03649555?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 5 participants. The study started on 2019-02-01. Estimated completion is 2021-03-03.
What interventions are being tested in trial NCT03649555?
The interventions under investigation include: [18F]-FTC-146 (DRUG).
Who is sponsoring clinical trial NCT03649555?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.